Valencell transforms the science of wearable biometrics to enable impactful health outcomes. Through innovative R&D and validated technologies, we develop breakthroughs and collaborate with wearables, hearables, and medical device companies around the world to deliver amazing results.

With more than 85 granted patents and 100+ patents pending around the world, Valencell’s technology continuously and accurately measures real-time biometric and physiological data that powers meaningful consumer and patient insights. Valencell was founded in 2006 and headquartered in Raleigh, North Carolina. Investors include Halma, Sonion, TDF Ventures, GII TECH, and WSJ Joshua Fund.

Health & Wellness

Valencell

Steven Leboeuf

L D.

Mark Felice

Scott Downing

Michael Aumer

Kevin McKinney

Dr. Steven Leboeuf

Leadership Team

Engineering and Development

Sales and Marketing

��

Teams at Valencell

Leadership Team

Engineering and Development

Sales and Marketing

��������

Teams at Valencell

Leadership Team

Engineering and Development

Sales and Marketing

��